- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech High ROE Growth Engines
Australian Pharmaceuticals & Biotech High ROE Growth Engines
Results
2
0 new
2 companies
Neuren Pharmaceuticals
Market Cap: AU$2.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.62
7D
2.0%
1Y
8.6%
EZZ Life Science Holdings
Market Cap: AU$100.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.12
7D
3.4%
1Y
11.3%